• 35069 Citations
  • 70 h-Index
19972020
If you made any changes in Pure these will be visible here soon.

Research Output 1997 2020

Filter
Comment/debate
Comment/debate
19 Citations (Scopus)

Checkpoint inhibitors in melanoma and early phase development in solid tumors: What's the future?

Ascierto, P. A. & McArthur, G. A., Aug 8 2017, In : Journal of Translational Medicine. 15, 1, 173.

Research output: Contribution to journalComment/debate

Tumors
Melanoma
Histology
Oncology
Toxicity

Correction: New paradigm for stage III melanoma: From surgery to adjuvant treatment (Journal of Translational Medicine (2019) 17 (266) DOI: 10.1186/s12967-019-2012-2)

Ascierto, P. A., Borgognoni, L., Botti, G., Guida, M., Marchetti, P., Mocellin, S., Muto, P., Palmieri, G., Patuzzo, R., Quaglino, P., Stanganelli, I. & Caracò, C., Sep 18 2019, In : Journal of Translational Medicine. 17, 1, 315.

Research output: Contribution to journalComment/debate

Open Access
Translational Medical Research
Fluorouracil
Surgery
Medicine
Publications
8 Citations (Scopus)
Italy
Melanoma
Neutrophils
Lymphocytes
ipilimumab
1 Citation (Scopus)
Conflict of Interest
Melanoma
Survival
Italy
Genes
22 Citations (Scopus)

Genetic instability and increased mutational load: Which diagnostic tool best direct patients with cancer to immunotherapy?

Palmieri, G., Colombino, M., Cossu, A., Marchetti, A., Botti, G. & Ascierto, P. A., Jan 21 2017, In : Journal of Translational Medicine. 15, 1, 17.

Research output: Contribution to journalComment/debate

Biomarkers
Immunotherapy
Tumors
Epitopes
Neoplasms
10 Citations (Scopus)

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

Masucci, G. V., Cesano, A., Eggermont, A., Fox, B. A., Wang, E., Marincola, F. M., Ciliberto, G., Dobbin, K., Puzanov, I., Taube, J., Wargo, J., Butterfield, L. H., Villabona, L., Thurin, M., Postow, M. A., Sondel, P. M., Demaria, S., Agarwala, S. & Ascierto, P. A., Nov 3 2017, In : Journal of Translational Medicine. 15, 1, 223.

Research output: Contribution to journalComment/debate

Biomarkers
Tumor Biomarkers
Immunotherapy
Toxicity
Clinical Trials